Работы, на которые ссылается эта работа

Работ: 257

Работа: Eurasian guidelines for the prevention and treatment of cardiovascular diseases in patients with obesity (2022)

Comparison of optimal point on the sternum for chest compression between obese and normal weight individuals with respect to body mass index, using computer tomography: A retrospective study
Juncheol Lee, Jaehoon Oh, Tae Ho Lim +5
Статья2018Цитирований: 2
ABI
Influence of BMI on inducible ventricular tachycardia and mortality in patients with myocardial infarction and left ventricular dysfunction: The obesity paradox
Rahul Samanta, Jim Pouliopoulos, Saurabh Kumar +7
Статья2018Цитирований: 2
ABI
PREVEntion and regReSsive Effect of weight-loss and risk factor modification on Atrial Fibrillation: the REVERSE-AF study
Melissa E. Middeldorp, Rajeev K. Pathak, Megan Meredith +12
Статья2018Цитирований: 2
ABI
An Overview and Update on Obesity and the Obesity Paradox in Cardiovascular Diseases
Andrew Elagizi, Sergey Kachur, Carl J. Lavie +4
Обзорная статья2018Цитирований: 2
ABI
Does body mass index truly affect mortality and cardiovascular outcomes in patients after coronary revascularization with percutaneous coronary intervention or coronary artery bypass graft? A systematic review and network meta‐analysis
Wenqi Ma, Xun Sun, Yiting Wang +3
Обзорная статья2018Цитирований: 2
ABI
Coronary Microvascular Dysfunction and Cardiovascular Risk in Obese Patients
Navkaranbir S. Bajaj, Michael T. Osborne, Ankur Gupta +10
Статья2018Цитирований: 2
ABI
Impact of body mass index on the outcome of catheter ablation of atrial fibrillation
Benedict M. Glover, Kathryn L. Hong, Nikolaos Dagres +12
Статья2018Цитирований: 2
ABI
Cardioversion of atrial fibrillation in obese patients: Results from the Cardioversion‐BMI randomized controlled trial
Aleksandr Voskoboinik, Jeremy Moskovitch, George Plunkett +15
Статья2018Цитирований: 2
ABI
Safety and Effectiveness of Electrical and Pharmacological Cardioversion in Persistent Atrial Fibrillation. Part I: Study Rationale, Design and Assessment of Effectiveness
N. Yu. Mironov, V. V. Vlodzyanovskiy, Yu. A. Yuricheva +4
Статья2018Цитирований: 2
ABI
Coronary Microvascular Disease Pathogenic Mechanisms and Therapeutic Options
Viviany R. Taqueti, Marcelo F. Di Carli
Обзорная статья2018Цитирований: 2
ABI
Reprint of: Healthy Weight and Obesity Prevention
Carl J. Lavie, Deepika Laddu, Ross Arena +3
Обзорная статья2018Цитирований: 2
ABI
Obesity as a Disease: The Obesity Society 2018 Position Statement
Ania M. Jastreboff, Catherine M. Kotz, Scott Kahan +2
Статья2018Цитирований: 2
ABI
Lean Mass Abnormalities in Heart Failure: The Role of Sarcopenia, Sarcopenic Obesity, and Cachexia
Salvatore Carbone, Hayley Billingsley, Paula Rodriguez‐Miguelez +5
Обзорная статья2019Цитирований: 2
ABI
<p>Obesity paradox in cardiovascular disease: where do we stand?</p>
Salvatore Carbone, Justin M. Canada, Hayley Billingsley +3
Обзорная статья2019Цитирований: 2
ABI
Heart Failure Association of the European Society of Cardiology Practical Guidance on the Use of Natriuretic Peptide Concentrations
Christian Mueller, Kenneth McDonald, Rudolf A. de Boer +15
Обзорная статья2019Цитирований: 2
ABI
Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
Scott D. Solomon, John J.V. McMurray, Inder S. Anand +31
Статья2019Цитирований: 2
ABI
Use of fenofibrate on cardiovascular outcomes in statin users with metabolic syndrome: propensity matched cohort study
Nam Hoon Kim, Ki Hoon Han, Jimi Choi +2
Статья2019Цитирований: 2
ABI
Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure
Scott D. Solomon, Muthiah Vaduganathan, Brian Claggett +22
Статья2019Цитирований: 2
ABI
Optimized electrocardiographic criteria for the detection of left ventricular hypertrophy in obesity patients
Sanne M. Snelder, Sweder W.E. van de Poll, Lotte E. de Groot–de Laat +3
Статья2020Цитирований: 2
ABI
AST/ALT ratio predicts the functional severity of chronic heart failure with reduced left ventricular ejection fraction
Mohammed Ewid, Hossam Sherif, Abdulaziz S. Allihimy +4
Статья2020Цитирований: 2
ABI
Antihypertensive and Vasoprotective Effects of Combined Pharmacotherapy in Patients with Arterial Hypertension and Prediabetes
V. V. Skibitskiy, S. R. Gutova, А. В. Фендрикова +1
Статья2020Цитирований: 2
ABI
A Randomized Trial of Intensive versus Standard Blood-Pressure Control
The SPRINT Research Group
Статья2015Цитирований: 2
ABI
Supervised Obesity Reduction Trial for AF ablation patients: results from the SORT-AF trial
Nele Geßler, Stephan Willems, Daniel Steven +13
Статья2021Цитирований: 2
ABI
Obesity cardiomyopathy: evidence, mechanisms, and therapeutic implications
Jun Ren, Ne N. Wu, Shuyi Wang +2
Обзорная статья2021Цитирований: 2
ABI
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease
Donna K. Arnett, Roger S. Blumenthal, Michelle A. Albert +15
Статья2019Цитирований: 2
ABI